ACTONEL COMBI

This brand name is authorized in the following countries: France Ireland United Kingdom

Active ingredients

The drug ACTONEL COMBI contains a combination of these active pharmaceutical ingredients (APIs):

UNII HU2YAQ274O - RISEDRONATE SODIUM HEMI-PENTAHYDRATE

Risedronic acid is a pyridinyl bisphosphonate that binds to bone hydroxyapatite and inhibits osteoclast-mediated bone resorption. The bone turnover is reduced while the osteoblast activity and bone mineralisation is preserved.

Read about Risedronic acid
UNII H0G9379FGK - CALCIUM CARBONATE

Calcium carbonate releases, in a pH-dependent manner, calcium ions in the stomach. Calcium carbonate is widely used as antacid and extensively used as a dietary supplement.

Read about Calcium carbonate

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code
Group title
Classification
M05BB02
Risedronic acid and calcium, sequential
M Musculo-skeletal system → M05 Drugs for treatment of bone diseases → M05B Drugs affecting bone structure and mineralization → M05BB Bisphosphonates, combinations
Discover more medicines within M05BB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country
Identification scheme
Identifier(s)
FR
Base de données publique des médicaments
Identifier(s): 64566299
GB
Medicines & Healthcare Products Regulatory Agency
Identifier(s): 132090
IE
Health Products Regulatory Authority
Identifier(s): 10603

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈